Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - powder for solution for infusion - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, clostridium perfringens, and peptostreptococcus micros.community-acquired bacterial pneumonia:community-acquired bacterial pneumonia caused by streptococcus pneumoniae (penicillin susceptible isolates), including cases with concurrent bacteremia, haemophilus influenzae (beta-lactamase negative isolates), and legionella pneumophila.

Malta - English - Medicines Authority

cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - fluorocholine - solution for injection - fluorocholine (18-f) 225 mbq/ml - diagnostic radiopharmaceuticals

Israel - English - Ministry of Health

vertex pharmaceuticals (u.k) limited, israel - ivacaftor; tezacaftor - film coated tablets - ivacaftor 150 mg; tezacaftor 100 mg - ivacaftor and tezacaftor - symdeko is a combination of tezacaftor and ivacaftor, indicated for the treatment of patients with cystic fibrosis (cf) aged 12 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.if the patient’s genotype is unknown, a health authority cleared cf mutation test should be used to detect the presence of a cftr mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use.

Israel - English - Ministry of Health

vertex pharmaceuticals (u.k) limited, israel - ivacaftor; tezacaftor - film coated tablets - ivacaftor 150 mg; tezacaftor 100 mg - ivacaftor and tezacaftor - symdeko is a combination of tezacaftor and ivacaftor, indicated for the treatment of patients with cystic fibrosis (cf) aged 12 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.if the patient’s genotype is unknown, a health authority cleared cf mutation test should be used to detect the presence of a cftr mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - it is indicated for the correction of myopia and hyperopia. the lens is intended for single patient use and for daily wear.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - it is indicated for the correction of visual acuity in aphakic and non-aphakic persons with non-diseased eyes with myopia or hyperopia. the lens may be worn by persons who exhibit refractive astigmatism of 2.00 dioptres or less where the astigmatism does not interfere with visual acuity.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - it is indicated for the correction of refractive ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes that may exhibit refractive and/or corneal astigmatism up to 2.00 dioptres that does not interfere with visual acuity.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - it is indicated for the correction of refractive ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes that may exhibit refractive and/or corneal astigmatism up to 2.00 dioptres that does not interfere with visual acuity.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - it is indicated for the correction of visual acuity in aphakic and non-aphakic persons with non-diseased eyes with myopia or hyperopia. the lens maybe worn by persons who exhibit refractive astigmatism of 0.75 dioptres or less where the astigmatism does not interfere with visual acuity.

Singapore - English - HSA (Health Sciences Authority)

international contact lens pte. ltd. - ophthalmology - the icontact soft contact lenses for daily wear are indicated for the correction of myopia and hyperopia in aphakic or non-aphakic persons with non-diseased